Health Care/Hospital
Molecular Data Inc. intends to further upgrade its digital tools using Blockchain
SHANGHAI, April 1, 2021 /PRNewswire/ -- Molecular Data Inc. ("Molecular Data" or the "Company") (Nasdaq: MKD), a leading technology-driven platform inChina's chemical industry, announced that it has signed a cooperation agreement with Dalian Lianhua Chemical Co., Ltd. ("Dalian Lianhua"), a leadin...
2021-04-01 19:00
2937
Ping An AskBob Doctor's Smart Imaging Model for Diagnosis of Pelvic and Hip Injuries is a Breakthrough for Artificial Intelligence
HONG KONG and SHANGHAI, April 1, 2021 /PRNewswire/ -- Ping An Insurance (Group) Company ofChina, Ltd. (hereafter "Ping An" or the "Group", HKEX: 2318; SSE: 601318) is pleased to announce that Ping An AskBob Doctor's smart imaging model for diagnosing pelvic and hip injuries is the first of its ki...
2021-04-01 17:17
3081
MGI COVID-19 Container Lab Put to Test, Safeguarding the World Figure Skating Championships
STOCKHOLM, April 1, 2021 /PRNewswire/ -- The weeklong ISU World Figure Skating Championships (the Championships), an Olympic qualification event, were held in Stockholm, Sweden in late March. The world's top figure skaters from around the world had travelled toSweden to compete for the title of wo...
2021-04-01 16:31
18161
Jolly Good Newly Establishes CBT VR Specialist Department with Clinical Psychiatrists
TOKYO, April 1, 2021 /PRNewswire/ -- Leading Japanese medical VR company Jolly
Good Inc. has recently established a specialized DTx Division to develop
digital therapeutics (hereinafter "DTx") using VR and AI technologies.
Logo: https://kyodonewsprwire.jp/img/202103313079-O1-CAsOT26u
2021-04-01 16:00
1713
Sophie's Bionutrients Unveils The World's First Plant-Based Burger Patty Made From Microalgae
SINGAPORE, April 1, 2021 /PRNewswire/ -- Sophie's Bionutrients, a
next-generation sustainable urban food production technology company, has
pushed the frontiers of plant-based food by developing burger patties made from
microalgae.
2021-04-01 14:25
70084
Yingli Pharma announce promising topline results of a Phase II registration study for treatment of relapsed/refractory follicular lymphoma with the once daily oral PI3Kδ inhibitor, linperlisib
* Linperlisib provides significant clinical improvement in the treatment for patients with relapsed and/or refractory follicular lymphoma * Linperlisib has a differentiated and well manageable safety profile SHANGHAI ,March 31, 2021 /PRNewswire/ -- Shanghai Yingli Pharmaceutical Co., Ltd. (Y...
2021-04-01 14:09
1804
CKGSB Economist Develops Dynamic Model for Reopening Strategies amid COVID-19
BEIJING, April 1, 2021 /PRNewswire/ -- With the COVID-19 vaccine being rolled out, many local and national governments are assessing how to safely reopen their economies while curtailing the number of positive cases. Professor of Economics,Zhong Ling, at the Cheung Kong Graduate School of Busines...
2021-04-01 13:36
1599
Frontier Pharma and Baystone Group completes its acquisition of Zdravlje, a high quality pharmaceutical manufacturer in Serbia
- Zdravlje is a leading pharmaceutical manufacturer which supplies more than 35 countries around the world - The Company has a 65+ year track record in supplying high quality pharmaceutical products across oral solid and liquid forms - Zdravlje represents a solid foundation upon which a le...
2021-04-01 13:00
5379
First-pass success in mechanical thrombectomy lowers costs in treatment of acute ischemic stroke in Asia Pacific
SINGAPORE, April 1, 2021 /PRNewswire/ -- A recent study published in the
Journal of Stroke
2021-04-01 11:15
6633
Dermlaze Offers Tips for Beauty Enthusiasts for the Upcoming Holiday Season
PETALING JAYA, Malaysia, April 1, 2021 /PRNewswire/ -- With the holiday season on the horizon, beauty enthusiasts are eagerly scouting ways to achieve different looks. Dr. Jeswender Singh, the leading doctor of Dermlaze Skin Lazer Aesthetics Centre, shares four tips to select the best aesthetic c...
2021-04-01 09:00
3582
Alfasigma: It's Vein Week from 5th to 11th of April
v-WIN Foundation and Alfasigma together to fight one of the leading causes of preventable death: venous thrombosis Italy as the hub of an international public awareness project on venous and lymphatic health of the legs to be presented inDUBAI during the EXPO An innovative geo-localization softw...
2021-04-01 08:35
3316
Ortho Announces Plans to Accelerate COVID-19 Antigen and Antibody Test Development Through New Contract with BARDA and the Department of Defense
RARITAN, N.J., April 1, 2021 /PRNewswire/ -- Ortho Clinical Diagnostics (Nasdaq: OCDX), one of the world's largest pure-play IVD companies, today announced that through its continued partnership with the Biomedical Advanced Research and Development Authority (BARDA) and the U.S. Department of Def...
2021-04-01 08:03
2027
Increased Virtual Learning Impacts Children's Vision
Expert panel on vision and health highlights the effects of screen-based learning on children's vision one year into the pandemic DALLAS, April 1, 2021 /PRNewswire/ -- The Vision Impact Institute recently convened experts in children's vision and health todiscuss the implications of digital lear...
2021-04-01 04:45
1977
Havas Health & You Expands International Business Footprint; Elevates Leaders in India, Southeast Asia & Middle East
MUMBAI, India, April 1, 2021 /PRNewswire/ -- After experiencing significant successes in the region following the acquisition of Sorento in 2017, Havas Health & You, with the intention to propel this growth and strengthen meaningful global partnerships, has announced the elevation ofSusan Josi as...
2021-04-01 03:30
1523
Iconovo signs agreement with ISR for the development of inhaled covid-19 vaccine
STOCKHOLM, April 1, 2021 /PRNewswire/ -- Iconovo AB (publ), a company developing complete inhalation products for a global market, today announced that it has signed an agreement with the immunotherapy company Immune System Regulation AB (ISR), an affiliate to ISR Immune System Regulation Holding...
2021-04-01 03:19
1435
VISEN's TransCon Human Growth Hormone Phase-III Clinical Trial in China Completes Target Patient Recruitment Number as Scheduled
SHANGHAI, March 31, 2021 /PRNewswire/ -- VISEN Pharmaceuticals, a biotech company committed to the treatment of endocrine-related diseases, announced on March 30 that it had successfully completed its recruiting target of 150 subjects for the Phase-III registration clinical trial inChina to evalu...
2021-03-31 23:53
2223
Ascentage Pharma Announces 2020 Annual Results and Reports Launch Readiness for Its Core Drug Candidate
SUZHOU, China and ROCKVILLE, Md., March 31, 2021 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today released its annual results for full ...
2021-03-31 23:27
3214
Five New 'Key Opinion Leaders' Appointed to Blinkcns Scientific Advisory Board
Dr. Angelo Antonini, Dr. Matteo Bologna, Roy Jones, Dr. Fidias Leon-Sarmiento, and Dr.Fabrizio Stocchi, will help guide company as they advance central nervous system research CHARLESTON, South Carolina, March 31, 2021 /PRNewswire/ -- Blinkcns, Inc, a biotechnology company pioneering blink refle...
2021-03-31 21:00
1008
Gracell Biotechnologies Signs Agreement with Lonza to Manufacture Gracell's FasTCAR Product Candidates in the U.S.
SUZHOU, China and PALO ALTO, Calif., March 31, 2021 /PRNewswire/ -- Gracell Biotechnologies Inc. (NASDAQ:GRCL)("Gracell"), a global clinical-stage biopharmaceutical company dedicated to discovering and developing highly efficacious and affordable cell therapies for the treatment of cancer, today ...
2021-03-31 20:45
3568
VolitionRx Limited Announces Publication of Significant Nu.Q® Capture Mass Spectrometry Paper
AUSTIN, Texas, March 31, 2021 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company developing simple, easy to use, cost effective blood tests to help diagnose a range of cancers and other diseases in both humans and animals, announced today t...
2021-03-31 20:30
2033
Week's Top Stories
Most Reposted
ABL Bio Receives Upfront Payment for License, Research and Collaboration Agreement for Grabody Platform and Equity Investment from Lilly
[Picked up by 278 media titles]
2025-12-26 12:55ACEN completes transition to 100% renewable energy
[Picked up by 273 media titles]
2025-12-29 18:53Vietnam's Newest EDM Destination, APLUS SAIGON, Debuts With Star-Studded Soft Opening Weekends Featuring Dombresky and Argy
[Picked up by 273 media titles]
2025-12-30 20:12
iQIYI LAND Yangzhou to Open on February 8, Marking New Chapter in China's Immersive Entertainment Scene
[Picked up by 271 media titles]
2026-01-01 10:00
CYFIRMA's 2025 Impact Recap Showcases DeCYFIR, Preemptive External Threat Landscape Management Platform, Delivering Measurable Global Defense Against Emerging Threats
[Picked up by 263 media titles]
2025-12-29 09:00
